Previous bioinformatics analysis showed that the regulatory target of the PZD components involved the AKT protein, so the WB experiment was used to verify whether PZD could regulate the malignant phenotypic characteristics of lung cancer cells through the PI3K/AKT signaling pathway. The gene discussed is AKT1; the disease is lung carcinoma.